Format

Send to

Choose Destination
Neural Regen Res. 2020 Feb;15(2):242-250. doi: 10.4103/1673-5374.265544.

Current status and future prospects of stem cell therapy in Alzheimer's disease.

Author information

1
Scientific Research Centre of China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China.
2
School of Life Sciences, Jilin University, Changchun, Jilin Province, China.

Abstract

Alzheimer's disease is a common progressive neurodegenerative disorder, pathologically characterized by the presence of β-amyloid plaques and neurofibrillary tangles. Current treatment approaches using drugs only alleviate the symptoms without curing the disease, which is a serious issue and influences the quality of life of the patients and their caregivers. In recent years, stem cell technology has provided new insights into the treatment of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Currently, the main sources of stem cells include neural stem cells, embryonic stem cells, mesenchymal stem cells, and induced pluripotent stem cells. In this review, we discuss the pathophysiology and general treatment of Alzheimer's disease, and the current state of stem cell transplantation in the treatment of Alzheimer's disease. We also assess future challenges in the clinical application and drug development of stem cell transplantation as a treatment for Alzheimer's disease.

KEYWORDS:

Alzheimer’s disease; drug development; embryonic stem cells; induced pluripotent stem cells; mesenchymal stem cells; nerve regeneration; neural regeneration; neural stem cells; neurodegenerative disorders; stem cell therapy; β-amyloid

PMID:
31552889
DOI:
10.4103/1673-5374.265544
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center